相关实验视频

Updated: Jul 8, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

对调节辅助T细胞免疫活动的脂质纳米颗粒进行查,以提高抗瘤活性

Yining Zhu^1,2,3, Jingyao Ma^2,3,4,5, Ruochen Shen^1,2,3

¹Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Nature biomedical engineering

|December 11, 2023

概括

优化脂质纳米粒子 (LNP) 提高了癌症疫苗的mRNA输送. 特定的LNP配方增强免疫细胞活性,具有强大的抗瘤作用,特别是与免疫检查点抑制剂.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
纳米医学是一种纳米医学.

背景情况:

脂质纳米粒子 (LNP) 对于提供基于mRNA的疗法至关重要.
可以通过改进抗原呈现细胞吸收和成熟来改进癌症免疫疗法.
调节LNP组成是优化对瘤的免疫反应的关键.

研究的目的:

开发和应用一种LNP选方法,以优化脂质成分和比率.
增强mRNA向树突细胞的传递,并改善其免疫激活特征.
通过定制的LNP介导免疫反应来实现增强的抗瘤活性.

主要方法:

查LNP以增强树突细胞成熟和抗原呈现 in vitro.
在小鼠黑色素瘤模型中评估免疫激活和瘤生长抑制.
评估LNP的皮下和肌肉内输送路径.

主要成果:

确定了最佳的LNP组合,以增强mRNA传递和免疫激活.
显示出强大的抗瘤活性,特别是当LNP与免疫检查点抑制剂相结合时.
观察到有效的LNP触发了协调的T细胞和NK细胞攻击,激活了1型和2型T辅助细胞.

结论:

在mRNA癌症疫苗中定制抗原特异性免疫激活配置文件时,LNP成分至关重要.
优化的LNP可以引起强大的免疫反应,导致显著的瘤生长抑制.
这些发现强调了基于LNP的mRNA疫苗在癌症免疫治疗中的潜力.

更多相关视频

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.